SciELO - Scientific Electronic Library Online

 
vol.30 issue3Malignancy after renal transplantation: a single-centre experienceHemodialysis Reliable Outflow (HeRO) Graft device: a lifesaving solution in multiple vascular access failure in haemodialysis patients author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Portuguese Journal of Nephrology & Hypertension

Print version ISSN 0872-0169

Abstract

BORGES, Tiago et al. Chronic myelomonocytic leukaemia: a presentation with rare extramedullary involvement. Port J Nephrol Hypert [online]. 2016, vol.30, n.3, pp.210-216. ISSN 0872-0169.

A 74-year-old male with a recent diagnosis of chronic myelomonocytic leukaemia (CMML) was admitted for rapidly progressive renal failure (RPRF), associated with gait impairment due to muscle weakness and pain in the lower limbs. After exclusion of pre-renal and post-renal causes of RPRF, the workup revealed monocytosis, high levels of inflammatory markers, hypergammaglobulinaemia, nephrotic proteinuria and high serum and urinary lysozyme levels. Renal biopsy confirmed the diagnosis of lysozyme-induced kidney injury and CMML-associated vasculitis. An electromyogram also revealed sensorimotor axonal polyneuropathy. The patient was started on prednisolone and azacitidine. Improvement of limb symptoms and a decrease in monocyte count, renal function values, inflammatory markers and proteinuria were subsequently seen. Although lysozyme levels are consistently elevated in CMML, lysozyme-induced kidney injury is a rare cause of renal failure. Filtered lysozyme appears to act as a direct tubular toxin and lysozymuria has been proposed as a valuable tool for detection of tubular damage. Polyneuropathy secondary to CMML is also infrequent and may be due to autoimmune mechanisms. We describe a case of lysozyme-induced kidney injury, vasculitis and axonal polyneuropathy, presumably secondary to CMML, in which prednisolone and azacitidine seem to have been helpful in treating extramedullary leukaemic involvement

Keywords : Chronic myelomonocytic leukaemia; lysozyme; polyneuropathy; rapidly progressive renal failure; vasculitis.

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License